Form 4: TD SYNNEX Director Richard T. Hume Sells Shares Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4


Director Richard T. Hume of TD SYNNEX CORP executed multiple sales of common stock on February 3, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • Richard T. Hume, a director of TD SYNNEX CORP, reported the sale of common stock on February 3, 2025.
  • The sales were executed under a Rule 10b5-1 trading plan adopted on June 28, 2024.
  • A total of 20,000 shares were sold in multiple transactions at prices ranging from $138.935 to $141.505.
  • Following the reported transactions, Hume still beneficially owns 85,480 shares of TD SYNNEX CORP common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports transactions under a pre-existing trading plan. It doesn't inherently indicate positive or negative sentiment about the company's future prospects.

Industry Context

Insider sales are a common occurrence, and the use of a 10b5-1 plan suggests the sales were pre-planned and not based on any specific non-public information. Investors often monitor insider transactions for signals about a company's prospects, but sales under a 10b5-1 plan are generally viewed as less informative.

Stakeholder Impact

  • The stock sale could have a minor negative impact on shareholder sentiment, although the existence of a 10b5-1 plan mitigates this concern.
  • The sale does not directly impact employees, customers, suppliers, or creditors.

Key Dates

DateDescription
2024/06/28Date of adoption of Rule 10b5-1 trading plan
2025/02/03Date of stock sale transactions
2025/02/04Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.